Cargando…
Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral Center
Despite the dramatic improvements in recurrence-free survival in patients with metastatic melanoma treated with immune checkpoint inhibitors (ICI), a number of patients develop metastases during adjuvant therapy. It is not currently possible to predict which patients are most likely to develop disea...
Autores principales: | Kurzhals, Jonas K., Klee, Gina, Hagelstein, Victoria, Zillikens, Detlef, Terheyden, Patrick, Langan, Ewan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505359/ https://www.ncbi.nlm.nih.gov/pubmed/36142629 http://dx.doi.org/10.3390/ijms231810723 |
Ejemplares similares
-
The impact of the Covid-19 pandemic on quality of life in skin cancer patients
por: Kurzhals, Jonas K., et al.
Publicado: (2021) -
Serum Troponin T Concentrations Are Frequently Elevated in Advanced Skin Cancer Patients Prior to Immune Checkpoint Inhibitor Therapy: Experience From a Single Tertiary Referral Center
por: Kurzhals, Jonas K., et al.
Publicado: (2021) -
Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma: A case report
por: Langan, Ewan A., et al.
Publicado: (2021) -
Sequential Treatment With Targeted and Immune Checkpoint Therapy in Patients With BRAF Positive Metastatic Melanoma: The Importance of Timing?
por: Grätz, Victoria, et al.
Publicado: (2019) -
The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis
por: Klee, Gina, et al.
Publicado: (2021)